Bedrocan’s recent collapse, which has endangered the supply of life-saving epilepsy medicine for dozens of patients across Europe, could soon be revived under a new entity.
Over the last week, a number of key developments have provided some much-needed clarity on the future of Bedrocan’s various entities and the future supply of its products to patients internationally.
On Friday (November 06), the Dutch Minister of Health wrote to the House of Representatives (Tweede Kamer) on this issue, the first public statement on the issue since the company’s insolvency. Days later, the court-appointed trustees filed their First Public Bankruptcy Report. Each confirms the restart is underway while setting out the stock, supply and…